Scienture Holdings, Inc.
For the period ended Dec 31, 2024. Filed Mar 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 26, 2025
SCNX$3.20+2.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplemental Data
| ITEM 8. | FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA |
|---|
Scienture Holdings, Inc. formerly TRxADE HEALTH, INC.
FORM 10-K
For the Year Ended December 31, 2024
TABLE OF CONTENTS
| REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM PCAOB ID: 6866 | 84 |
|---|---|
| CONSOLIDATED BALANCE SHEETS | 85 |
| CONSOLIDATED STATEMENTS OF OPERATIONS | 86 |
| CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY | 87 |
| CONSOLIDATED STATEMENTS OF CASH FLOWS | 88 |
| NOTES TO CONSOLIDATED FINANCIAL STATEMENTS | 89 |
PART II: FINANCIAL INFORMATION
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.